CSMA Invest in ToFSIMS to Boost Surface Analysis Capabilities

CSMA Invest in ToFSIMS to Boost Surface Analysis Capabilities

Underlining its commitment to provide the most sensitive possible testing and analysis service to its clients, Materials Analysis expert CSMA has invested half a million pounds in a new Time of Flight Secondary Ion Mass Spectrometers (TOF SIMS). This new technology will be used by CSMA's team of specialist surface scientists in surface characterisation and trouble shooting for a wide range of industries, including; pharmaceuticals, packaging, food, housewares. It will also help ensure that CSMA, which is part of CERAM, retains its world leading position in this area of technology.

CSMA already has many of the world's blue chip pharmaceutical, medical device, semiconductor and automotive and aerospace companies as its clients, and is now enjoying a period of development and expansion. This is being driven by the demands of its clients to perform ever more technologically demanding applications, looking at new product developments as well as technological support for patent claims.

The company has been involved in assisting developments in a broad range of applications from innovative drug encapsulations, cardiovascular stents, orthopaedic implants, laser surface cleaning studies for aerospace, proteins on surgical instruments etc.

CSMA now has North America in its sights as the next target for expansion, and it has a plan to set up a characterisation service in the USA during 2005. This will supplement the work that is already being secured through partner laboratories in the Far East.

The technology is not confined to large high tech companies however, as, through its parent company CERAM, CSMA is able to offer its services to many smaller companies with support from local agencies such as Advantage West Midlands.

For more information on the capabilities of Time of Flight Secondary Ion Mass Spectrometers (TOF SIMS), click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.